⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Amanys Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Amanys Pharma
↗Aïn El Aouda, Morocco
Amanys Pharma is a Moroccan pharmaceutical company established in 2011, specializing in the manufacturing of antibiotics (particularly penicillin-based products) and the distribution of hospital-focused pharmaceuticals, including injectable solutions and plasma derivatives. The company also provides contract manufacturing services for third parties and maintains a distribution network for hospitals across Morocco and sub-Saharan Africa.
In November 2023, Amanys Pharma was acquired by Laprophan, a pioneering Moroccan pharmaceutical laboratory with over 70 years of history. This merger aims to create a diversified pharmaceutical group with enhanced industrial and R&D capabilities to better serve the growing health needs in Morocco and the broader African continent.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Antibiotics and Hospital Pharmaceuticals
SIZE & FINANCIALS
Employees:51-200
Founded:2011
Ownership:subsidiary
Status:operating
FUNDING
Investors:SPE Capital, Proparco
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Laprophan
Acquired By:Laprophan (2023-11-01)
Subsidiaries:Amanys Pharma India Private Limited
Key Partnerships:Laprophan (Parent company), GlaxoSmithKline (Former manufacturing partner)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Moulay Younous Elalamy - General Manager
LINKS
Website:amanyspharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Amanys Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.